Cargando…
Targeted Modification and Structure-Activity Study of GL-29, an Analogue of the Antimicrobial Peptide Palustrin-2ISb
Antimicrobial peptides (AMPs) are considered as promising antimicrobial agents due to their potent bioactivity. Palustrin-2 peptides were previously found to exhibit broad-spectrum antimicrobial activity with low haemolytic activity. Therefore, GL-29 was used as a template for further modification a...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405102/ https://www.ncbi.nlm.nih.gov/pubmed/36009917 http://dx.doi.org/10.3390/antibiotics11081048 |
_version_ | 1784773798437847040 |
---|---|
author | Liu, Siyan Lin, Yaxian Liu, Jiachen Chen, Xiaoling Ma, Chengbang Xi, Xinping Zhou, Mei Chen, Tianbao Burrows, James F. Wang, Lei |
author_facet | Liu, Siyan Lin, Yaxian Liu, Jiachen Chen, Xiaoling Ma, Chengbang Xi, Xinping Zhou, Mei Chen, Tianbao Burrows, James F. Wang, Lei |
author_sort | Liu, Siyan |
collection | PubMed |
description | Antimicrobial peptides (AMPs) are considered as promising antimicrobial agents due to their potent bioactivity. Palustrin-2 peptides were previously found to exhibit broad-spectrum antimicrobial activity with low haemolytic activity. Therefore, GL-29 was used as a template for further modification and study. Firstly, the truncated analogue, GL-22, was designed to examine the function of the ‘Rana box’, which was confirmed to have no impact on antimicrobial activity. The results of antimicrobial activity assessment against seven microorganisms demonstrated GL-22 to have a broad-spectrum antimicrobial activity, but weak potency against Candida albicans (C. albicans). These data were similar to those of GL-29, but GL-22 showed much lower haemolysis and lower cytotoxicity against HaCaT cells. Moreover, GL-22 exhibited potent in vivo activity at 4 × MIC against Staphylococcus aureus (S. aureus)-infected larvae. Several short analogues, from the C-terminus and N-terminus of GL-22, were modified to identify the shortest functional motif. However, the results demonstrated that the shorter peptides did not exhibit potent antimicrobial activity, and the factors that affect the bioactive potency of these short analogues need to be further studied. |
format | Online Article Text |
id | pubmed-9405102 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94051022022-08-26 Targeted Modification and Structure-Activity Study of GL-29, an Analogue of the Antimicrobial Peptide Palustrin-2ISb Liu, Siyan Lin, Yaxian Liu, Jiachen Chen, Xiaoling Ma, Chengbang Xi, Xinping Zhou, Mei Chen, Tianbao Burrows, James F. Wang, Lei Antibiotics (Basel) Article Antimicrobial peptides (AMPs) are considered as promising antimicrobial agents due to their potent bioactivity. Palustrin-2 peptides were previously found to exhibit broad-spectrum antimicrobial activity with low haemolytic activity. Therefore, GL-29 was used as a template for further modification and study. Firstly, the truncated analogue, GL-22, was designed to examine the function of the ‘Rana box’, which was confirmed to have no impact on antimicrobial activity. The results of antimicrobial activity assessment against seven microorganisms demonstrated GL-22 to have a broad-spectrum antimicrobial activity, but weak potency against Candida albicans (C. albicans). These data were similar to those of GL-29, but GL-22 showed much lower haemolysis and lower cytotoxicity against HaCaT cells. Moreover, GL-22 exhibited potent in vivo activity at 4 × MIC against Staphylococcus aureus (S. aureus)-infected larvae. Several short analogues, from the C-terminus and N-terminus of GL-22, were modified to identify the shortest functional motif. However, the results demonstrated that the shorter peptides did not exhibit potent antimicrobial activity, and the factors that affect the bioactive potency of these short analogues need to be further studied. MDPI 2022-08-03 /pmc/articles/PMC9405102/ /pubmed/36009917 http://dx.doi.org/10.3390/antibiotics11081048 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Liu, Siyan Lin, Yaxian Liu, Jiachen Chen, Xiaoling Ma, Chengbang Xi, Xinping Zhou, Mei Chen, Tianbao Burrows, James F. Wang, Lei Targeted Modification and Structure-Activity Study of GL-29, an Analogue of the Antimicrobial Peptide Palustrin-2ISb |
title | Targeted Modification and Structure-Activity Study of GL-29, an Analogue of the Antimicrobial Peptide Palustrin-2ISb |
title_full | Targeted Modification and Structure-Activity Study of GL-29, an Analogue of the Antimicrobial Peptide Palustrin-2ISb |
title_fullStr | Targeted Modification and Structure-Activity Study of GL-29, an Analogue of the Antimicrobial Peptide Palustrin-2ISb |
title_full_unstemmed | Targeted Modification and Structure-Activity Study of GL-29, an Analogue of the Antimicrobial Peptide Palustrin-2ISb |
title_short | Targeted Modification and Structure-Activity Study of GL-29, an Analogue of the Antimicrobial Peptide Palustrin-2ISb |
title_sort | targeted modification and structure-activity study of gl-29, an analogue of the antimicrobial peptide palustrin-2isb |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405102/ https://www.ncbi.nlm.nih.gov/pubmed/36009917 http://dx.doi.org/10.3390/antibiotics11081048 |
work_keys_str_mv | AT liusiyan targetedmodificationandstructureactivitystudyofgl29ananalogueoftheantimicrobialpeptidepalustrin2isb AT linyaxian targetedmodificationandstructureactivitystudyofgl29ananalogueoftheantimicrobialpeptidepalustrin2isb AT liujiachen targetedmodificationandstructureactivitystudyofgl29ananalogueoftheantimicrobialpeptidepalustrin2isb AT chenxiaoling targetedmodificationandstructureactivitystudyofgl29ananalogueoftheantimicrobialpeptidepalustrin2isb AT machengbang targetedmodificationandstructureactivitystudyofgl29ananalogueoftheantimicrobialpeptidepalustrin2isb AT xixinping targetedmodificationandstructureactivitystudyofgl29ananalogueoftheantimicrobialpeptidepalustrin2isb AT zhoumei targetedmodificationandstructureactivitystudyofgl29ananalogueoftheantimicrobialpeptidepalustrin2isb AT chentianbao targetedmodificationandstructureactivitystudyofgl29ananalogueoftheantimicrobialpeptidepalustrin2isb AT burrowsjamesf targetedmodificationandstructureactivitystudyofgl29ananalogueoftheantimicrobialpeptidepalustrin2isb AT wanglei targetedmodificationandstructureactivitystudyofgl29ananalogueoftheantimicrobialpeptidepalustrin2isb |